BriaCell Therapeutics Corp. Warrant expiring 2031 share price logo

BriaCell Therapeutics Corp. Warrant expiring 2031 Share Price

NASDAQ: BCTXL

$1.07

-0.01

(-1.38%)

as on

BriaCell Therapeutics Corp. Warrant expiring 2031 Stock Performance

as on April 18, 2026 at 6:56 am IST

  • Day's Low

    Day's High

    $1.06
    $1.16
    downward going graph

    0.93%

    Downside

    8.41%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

BriaCell Therapeutics Corp. Warrant expiring 2031 share price movements today

Previous Close
$1.08
Open
$1.16
Volume
862.1K
Day's Low - High
$1.06 - $1.16

BriaCell Therapeutics Corp. Warrant expiring 2031 Historical Returns

1 Month Return
-9.58 %
3 Month Return
+ 8.5 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

BriaCell Therapeutics Corp. Warrant expiring 2031 Stock Fundamentals & Key Indicators

Check BriaCell Therapeutics Corp. Warrant expiring 2031 market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-179.21%

BriaCell Therapeutics Corp. Warrant expiring 2031 stock Key Stats

Compare market cap, revenue, PE, and other key metrics of BriaCell Therapeutics Corp. Warrant expiring 2031 with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BriaCell Therapeutics Corp. Warrant expiring 2031 image
BriaCell Therapeutics Corp. Warrant expiring 2031
NA$-NANA0.00%

BriaCell Therapeutics Corp. Warrant expiring 2031 Stock’s Investor Sentiment and Interest

Search interest for BriaCell Therapeutics Corp. Warrant expiring 2031 Stock has decreased by -12% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-12% versus previous 30 day period

About BriaCell Therapeutics Corp. Warrant expiring 2031

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp., has a collaboration with MSK Accelerator to accelerate theclinical development of Bria-OTS+ for multiple cancer indications including metastatic breast cancer, prostate cancer, and other cancers. The company is headquartered in West Vancouver, Canada.
OrganisationBriaCell Therapeutics Corp. Warrant expiring 2031
HeadquartersBellevue Centre, West Vancouver, BC, Canada, V7T 2X1
IndustryMiscellaneous
CEODr. William V. Williams FCPA, M.D.
E-voting on sharesClick here to vote

Key Management of BriaCell Therapeutics Corp. Warrant expiring 2031

Name

Title

Mr. Gadi Levin B.Com., C.A., CPA, M.B.A.

CFO & Corporate Secretary

Dr. Miguel A. Lopez-Lago Ph.D.

Chief Scientific Officer

Dr. Giuseppe Del Priore M.D., M.P.H.

Chief Medical Officer

Dr. Charles Louis Wiseman FACP, M.D.

Founder, Principal Research Advisor & Member of Scientific Advisory Board

Dr. William V. Williams FCPA, M.D.

CEO, President & Director

FAQs

What is BriaCell Therapeutics Corp. Warrant expiring 2031 share price today?

BriaCell Therapeutics Corp. Warrant expiring 2031 share price today is $1.07 as on at the close of the market. BriaCell Therapeutics Corp. Warrant expiring 2031 share today touched a day high of $1.16 and a low of $1.06.

What is the 52 week high and 52 week low for BriaCell Therapeutics Corp. Warrant expiring 2031 share?

BriaCell Therapeutics Corp. Warrant expiring 2031 share touched a 52 week high of $ on and a 52 week low of $ on . BriaCell Therapeutics Corp. Warrant expiring 2031 stock price today i.e. is closed at $1.07,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

How to invest in BriaCell Therapeutics Corp. Warrant expiring 2031 Stock (BCTXL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for BriaCell Therapeutics Corp. Warrant expiring 2031 on INDmoney app. Click on Buy button. You can invest as low as $1.5 in BriaCell Therapeutics Corp. Warrant expiring 2031 Shares that will get you 1.4019 shares as per BriaCell Therapeutics Corp. Warrant expiring 2031 share price of $1.07 per share as on April 18, 2026 at 1:26 am IST.

What is the minimum amount required to buy BriaCell Therapeutics Corp. Warrant expiring 2031 Stock (BCTXL) from India?

Indian investors can start investing in BriaCell Therapeutics Corp. Warrant expiring 2031 (BCTXL) shares with as little as ₹92.768 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹927.68 in BriaCell Therapeutics Corp. Warrant expiring 2031 stock (as per the Rupee-Dollar exchange rate as on ). Based on BriaCell Therapeutics Corp. Warrant expiring 2031 share’s latest price of $1.07 as on April 18, 2026 at 1:26 am IST, you will get 9.3458 shares of BriaCell Therapeutics Corp. Warrant expiring 2031. Learn more about fractional shares .